VivoSeq
Other

Optical Coherence Tomography

0

Pipeline Programs↗

4

Active Trials↗

1

Companies Involved↗

Optical Coherence Tomography is an early-stage landscape with 0 programs across 1 company. The most active players are Novartis.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

93/100

Attrition Rate

4/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Novartis logo

Novartis

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

23

clinical trials

Completed13 · 57%
Unknown status5 · 22%
Recruiting4 · 17%
Withdrawn1 · 4%

Clinical Trials

Trial Activity

23 trials

Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography
Recruiting·—·Phase 4·NCT06520904·396 enrolled
The Value of Measuring Retinal Vascular Density by Optical Coherence Tomography-Angiography (OCT-A) in Patients With Microvascular Angina Confirmed by Myocardial Microcirculatory Resistance Index (MRI).
Recruiting·—·N/A·NCT06692751·158 enrolled
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Recruiting·OOregon Health and Science University·N/A·NCT01243931·80 enrolled
Visualization of Topical Zoryve vs. Vehicle Using Line Field Optical Coherence Tomography in Healthy Skin
Recruiting·—·Phase 4·NCT06440473·3 enrolled
A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections
Completed·Novartis logoNovartis·N/A·NCT04662944·494 enrolled
ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography
Completed·—·Phase 4·NCT01594736·30 enrolled
Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound
Completed·TTechnische Universität Dresden·Phase 1·NCT00655512·40 enrolled
COmparison and Modification in Neointimal Pattern Assessed by Optical Coherence Tomography With High Versus Moderate Efficacy Statin Treatment After Drug Eluting Stent Implantation: COMPASS Trial
Completed·YYonsei University·N/A·NCT02155530·30 enrolled
Effects of External Testosteron Intake on the Choroid: Enhance-depth Imaging Optical Coherence Tomography Study
Completed·—·N/A·NCT04342247·30 enrolled
Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy
Completed·—·Phase 2·NCT04766437·75 enrolled
Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy
Completed·VVision Research Foundation·N/A·NCT01256632·40 enrolled
The Effect of Pioglitazone on Neointima Volume and Characteristics Observed by Optical Coherence Tomography (OCT)
Completed·KKorea University Anam Hospital·Phase 4·NCT01331967·94 enrolled
Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)
Completed·HHarbin Medical University·Phase 4·NCT01023607·120 enrolled
Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel
Completed·NNanjing First Hospital, Nanjing Medical University·Phase 4·NCT02140801·352 enrolled
Impact of PCSK9 Inhibitors on Coronary Plaque Composition and Vulnerability Assessed by Optical Coherence Tomography
Completed·—·Phase 4·NCT04851769·60 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)